|
1
|
Hoste EAJ, Kellum JA, Selby NM, Zarbock A,
Palevsky PM, Bagshaw SM, Goldstein SL, Cerdá J and Chawla LS:
Global epidemiology and outcomes of acute kidney injury. Nat Rev
Nephrol. 14:607–625. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kaddourah A, Basu RK, Bagshaw SM and
Goldstein SL; AWARE Investigators, : Epidemiology of acute kidney
injury in critically Ill children and young adults. N Engl J Med.
376:11–20. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chertow GM, Burdick E, Honour M, Bonventre
JV and Bates DW: Acute kidney injury, mortality, length of stay,
and costs in hospitalized patients. J Am Soc Nephrol. 16:3365–3370.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Susantitaphong P, Cruz DN, Cerda J,
Abulfaraj M, Alqahtani F, Koulouridis I and Jaber BL; Acute Kidney
Injury Advisory Group of the American Society of Nephrology, :
World incidence of AKI: A meta-analysis. Clin J Am Soc Nephrol.
8:1482–1493. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ronco C, Bellomo R and Kellum JA: Acute
kidney injury. Lancet. 394:1949–1964. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
James MT, Bhatt M, Pannu N and Tonelli M:
Long-term outcomes of acute kidney injury and strategies for
improved care. Nat Rev Nephrol. 16:193–205. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han SJ and Lee HT: Mechanisms and
therapeutic targets of ischemic acute kidney injury. Kidney Res
Clin Pract. 38:427–440. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Priante G, Gianesello L, Ceol M, Del Prete
D and Anglani F: Cell death in the kidney. Int J Mol Sci.
20:35982019. View Article : Google Scholar
|
|
9
|
Martin-Sanchez D, Poveda J,
Fontecha-Barriuso M, Ruiz-Andres O, Sanchez-Niño MD, Ruiz-Ortega M,
Ortiz A and Sanz AB: Targeting of regulated necrosis in kidney
disease. Nefrologia. 38:125–135. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kers J, Leemans JC and Linkermann A: An
overview of pathways of regulated necrosis in acute kidney injury.
Semin Nephrol. 36:139–152. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pefanis A, Ierino FL, Murphy JM and Cowan
PJ: Regulated necrosis in kidney ischemia-reperfusion injury.
Kidney Int. 96:291–301. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu Z, Zhang H, Yang SK, Wu X, He D, Cao K
and Zhang W: Emerging role of ferroptosis in acute kidney injury.
Oxid Med Cell Longev. 2019:80106142019. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dixon SJ, Lemberg KM, Lamprecht MR, Skouta
R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS,
et al: Ferroptosis: An iron-dependent form of nonapoptotic cell
death. Cell. 149:1060–1072. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li J, Cao F, Yin HL, Huang ZJ, Lin ZT, Mao
N, Sun B and Wang G: Ferroptosis: Past, present and future. Cell
Death Dis. 11:882020. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Linkermann A, Skouta R, Himmerkus N, Mulay
SR, Dewitz C, De Zen F, Prokai A, Zuchtriegel G, Krombach F, Welz
PS, et al: Synchronized renal tubular cell death involves
ferroptosis. Proc Natl Acad Sci USA. 111:16836–16841. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ling H, Zhang Y, Ng KY and Chew EH:
Pachymic acid impairs breast cancer cell invasion by suppressing
nuclear factor-κB-dependent matrix metalloproteinase-9 expression.
Breast Cancer Res Treat. 126:609–620. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li FF, Yuan Y, Liu Y, Wu QQ, Jiao R, Yang
Z, Zhou MQ and Tang QZ: Pachymic acid protects H9c2 cardiomyocytes
from lipopolysaccharide-induced inflammation and apoptosis by
inhibiting the extracellular signal-regulated kinase 1/2 and p38
pathways. Mol Med Rep. 12:2807–2813. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li JY, Wu HX and Yang G: Pachymic acid
improves survival and attenuates acute lung injury in septic rats
induced by cecal ligation and puncture. Eur Rev Med Pharmacol Sci.
21:1904–1910. 2017.PubMed/NCBI
|
|
19
|
Li TH, Hou CC, Chang CL and Yang WC:
Anti-hyperglycemic properties of crude extract and triterpenes from
poria cocos. Evid Based Complement Alternat Med. 2011:1284022011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shah VK, Choi JJ, Han JY, Lee MK, Hong JT
and Oh KW: Pachymic acid enhances pentobarbital-induced sleeping
behaviors via GABAA-ergic systems in mice. Biomol Ther (Seoul).
22:314–320. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cai ZY, Sheng ZX and Yao H: Pachymic acid
ameliorates sepsis-induced acute kidney injury by suppressing
inflammation and activating the Nrf2/HO-1 pathway in rats. Eur Rev
Med Pharmacol Sci. 21:1924–1931. 2017.PubMed/NCBI
|
|
22
|
Chen DQ, Feng YL, Chen L, Liu JR, Wang M,
Vaziri ND and Zhao YY: Poricoic acid A enhances melatonin
inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2
axis. Free Radic Biol Med. 134:484–497. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dodson M, Castro-Portuguez R and Zhang DD:
NRF2 plays a critical role in mitigating lipid peroxidation and
ferroptosis. Redox Biol. 23:1011072019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
National Research Council (US) Institute
for Laboratory Animal Research, . Guide for the Care and Use of
Laboratory Animals. Washington (DC): National Academies Press (US);
1996, simplehttps://www.ncbi.nlm.nih.gov/books/NBK232589/doi:
10.17226/5140.
|
|
25
|
Wei Q and Dong Z: Mouse model of ischemic
acute kidney injury: Technical notes and tricks. Am J Physiol Renal
Physiol. 303:F1487–F1494. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Paller MS, Hoidal JR and Ferris TF: Oxygen
free radicals in ischemic acute renal failure in the rat. J Clin
Invest. 74:1156–1164. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xie Y, Hou W, Song X, Yu Y, Huang J, Sun
X, Kang R and Tang D: Ferroptosis: Process and function. Cell Death
Differ. 23:369–379. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su L, Jiang X, Yang C, Zhang J, Chen B, Li
Y, Yao S, Xie Q, Gomez H, Murugan R and Peng Z: Pannexin 1 mediates
ferroptosis that contributes to renal ischemia/reperfusion injury.
J Biol Chem. 294:19395–19404. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Friedmann Angeli JP, Schneider M, Proneth
B, Tyurina YY, Tyurin VA, Hammond VJ, Herbach N, Aichler M, Walch
A, Eggenhofer E, et al: Inactivation of the ferroptosis regulator
Gpx4 triggers acute renal failure in mice. Nat Cell Biol.
16:1180–1191. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dixon SJ, Patel DN, Welsch M, Skouta R,
Lee ED, Hayano M, Thomas AG, Gleason CE, Tatonetti NP, Slusher BS
and Stockwell BR: Pharmacological inhibition of cystine-glutamate
exchange induces endoplasmic reticulum stress and ferroptosis.
Elife. 3:e025232014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yang WS, SriRamaratnam R, Welsch ME,
Shimada K, Skouta R, Viswanathan VS, Cheah JH, Clemons PA, Shamji
AF, Clish CB, et al: Regulation of ferroptotic cancer cell death by
GPX4. Cell. 156:317–331. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Cao JY and Dixon SJ: Mechanisms of
ferroptosis. Cell Mol Life Sci. 73:2195–2209. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kerins MJ and Ooi A: The roles of NRF2 in
modulating cellular iron homeostasis. Antioxid Redox Signal.
29:1756–1773. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Harada N, Kanayama M, Maruyama A, Yoshida
A, Tazumi K, Hosoya T, Mimura J, Toki T, Maher JM, Yamamoto M and
Itoh K: Nrf2 regulates ferroportin 1-mediated iron efflux and
counteracts lipopolysaccharide-induced ferroportin 1 mRNA
suppression in macrophages. Arch Biochem Biophys. 508:101–109.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Alam J, Stewart D, Touchard C, Boinapally
S, Choi AM and Cook JL: Nrf2, a Cap'n'Collar transcription factor,
regulates induction of the heme oxygenase-1 gene. J Biol Chem.
274:26071–26078. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Adedoyin O, Boddu R, Traylor A, Lever JM,
Bolisetty S, George JF and Agarwal A: Heme oxygenase-1 mitigates
ferroptosis in renal proximal tubule cells. Am J Physiol Renal
Physiol. 314:F702–F714. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chan JY and Kwong M: Impaired expression
of glutathione synthetic enzyme genes in mice with targeted
deletion of the Nrf2 basic-leucine zipper protein. Biochim Biophys
Acta. 1517:19–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yang H, Magilnick N, Lee C, Kalmaz D, Ou
X, Chan JY and Lu SC: Nrf1 and Nrf2 regulate rat glutamate-cysteine
ligase catalytic subunit transcription indirectly via NF-kappaB and
AP-1. Mol Cell Biol. 25:5933–5946. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sasaki H, Sato H, Kuriyama-Matsumura K,
Sato K, Maebara K, Wang H, Tamba M, Itoh K, Yamamoto M and Bannai
S: Electrophile response element-mediated induction of the
cystine/glutamate exchange transporter gene expression. J Biol
Chem. 277:44765–44771. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Salazar M, Rojo AI, Velasco D, de Sagarra
RM and Cuadrado A: Glycogen synthase kinase-3beta inhibits the
xenobiotic and antioxidant cell response by direct phosphorylation
and nuclear exclusion of the transcription factor Nrf2. J Biol
Chem. 281:14841–14851. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li X, Zou Y, Xing J, Fu YY, Wang KY, Wan
PZ and Zhai XY: Pretreatment with roxadustat (FG-4592) attenuates
folic acid-induced kidney injury through antiferroptosis via
Akt/GSK-3β/Nrf2 pathway. Oxid Med Cell Longev.
2020:62869842020.PubMed/NCBI
|
